ATE500829T1 - Antitumor-kombinationen mit einem vegf-hemmenden mittel und irinotecan - Google Patents
Antitumor-kombinationen mit einem vegf-hemmenden mittel und irinotecanInfo
- Publication number
- ATE500829T1 ATE500829T1 AT08827826T AT08827826T ATE500829T1 AT E500829 T1 ATE500829 T1 AT E500829T1 AT 08827826 T AT08827826 T AT 08827826T AT 08827826 T AT08827826 T AT 08827826T AT E500829 T1 ATE500829 T1 AT E500829T1
- Authority
- AT
- Austria
- Prior art keywords
- irinotecan
- vegf
- inhibiting agent
- antitumor combinations
- antitumor
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
- A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
- A61K39/3955—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against proteinaceous materials, e.g. enzymes, hormones, lymphokines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4738—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4745—Quinolines; Isoquinolines ortho- or peri-condensed with heterocyclic ring systems condensed with ring systems having nitrogen as a ring hetero atom, e.g. phenantrolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Endocrinology (AREA)
- Microbiology (AREA)
- Mycology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR0704868A FR2918279B1 (fr) | 2007-07-05 | 2007-07-05 | Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan |
PCT/FR2008/000943 WO2009024667A2 (fr) | 2007-07-05 | 2008-07-02 | Combinaisons antitumorales contenant un agent inhibiteur de vegf et de l'irinotecan |
Publications (1)
Publication Number | Publication Date |
---|---|
ATE500829T1 true ATE500829T1 (de) | 2011-03-15 |
Family
ID=38961256
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AT08827826T ATE500829T1 (de) | 2007-07-05 | 2008-07-02 | Antitumor-kombinationen mit einem vegf-hemmenden mittel und irinotecan |
Country Status (24)
Country | Link |
---|---|
US (3) | US20100160233A1 (de) |
EP (1) | EP2173349B1 (de) |
JP (4) | JP2010532335A (de) |
KR (4) | KR20150048910A (de) |
CN (3) | CN105833244A (de) |
AR (1) | AR067420A1 (de) |
AT (1) | ATE500829T1 (de) |
AU (1) | AU2008290442B2 (de) |
BR (1) | BRPI0812835B8 (de) |
CA (1) | CA2693152C (de) |
CY (1) | CY1111675T1 (de) |
DE (1) | DE602008005457D1 (de) |
DK (1) | DK2173349T3 (de) |
ES (1) | ES2362637T3 (de) |
FR (1) | FR2918279B1 (de) |
HR (1) | HRP20110432T1 (de) |
IL (2) | IL203132A (de) |
MX (1) | MX2009013950A (de) |
PL (1) | PL2173349T3 (de) |
PT (1) | PT2173349E (de) |
RS (1) | RS51777B (de) |
RU (1) | RU2471483C2 (de) |
SI (1) | SI2173349T1 (de) |
WO (1) | WO2009024667A2 (de) |
Families Citing this family (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1534340B1 (de) | 2002-09-06 | 2011-11-16 | Cerulean Pharma Inc. | Polymere auf basis von cyclodextrin zur verabreichung von an diese kovalent gebundene arzneimittel |
JP2010516625A (ja) | 2007-01-24 | 2010-05-20 | インサート セラピューティクス, インコーポレイテッド | 制御された薬物送達のためのテザー基を有するポリマー−薬物コンジュゲート |
US20110223241A1 (en) * | 2008-10-16 | 2011-09-15 | Celator Pharmaceuticals, Inc. | Combination methods and compositions |
ES2354922B1 (es) | 2009-09-02 | 2012-02-07 | Fundacion Institut De Recerca De L'hospital Universitari Vall D'hebron | Marcadores para la selección de terapias personalizadas para el tratamiento del c�?ncer. |
US20130029909A1 (en) * | 2009-09-15 | 2013-01-31 | John Ryan | Treatment of cancer |
KR20210030510A (ko) | 2011-01-13 | 2021-03-17 | 리제너론 파아마슈티컬스, 인크. | 혈관신생 눈 장애를 치료하기 위한 vegf 길항제의 용도 |
JO3283B1 (ar) * | 2011-04-26 | 2018-09-16 | Sanofi Sa | تركيب يتضمن أفليبيرسيبت, حمض فولينيك, 5- فلورويوراسيل (5- Fu) وإرينوسيتان (FOLFIRI) |
US20140094432A1 (en) | 2012-10-02 | 2014-04-03 | Cerulean Pharma Inc. | Methods and systems for polymer precipitation and generation of particles |
TR201909951T4 (tr) | 2014-07-18 | 2019-07-22 | Sanofi Sa | Kanser olduğundan şüphelenilen bir hastanın aflibersept ile tedavisinin sonucunun öngörülmesine yönelik yöntem. |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BRPI0011407B8 (pt) * | 1999-06-08 | 2021-05-25 | Regeneron Pharma | molécula de ácido nucléico quimérica, polipeptídeo de fusão, vetor de expressão, sistema de vetor hospedeiro, e, métodos de produzir um polipeptídeo de fusão |
DE60314378T2 (de) * | 2002-03-01 | 2008-02-28 | Pfizer Italia S.R.L. | Kristalline polymorphe form von irinotecanhydrochlorid |
AR046510A1 (es) * | 2003-07-25 | 2005-12-14 | Regeneron Pharma | Composicion de un antagonista de vegf y un agente anti-proliferativo |
JP2007501239A (ja) * | 2003-08-06 | 2007-01-25 | リジェネロン・ファーマシューティカルズ・インコーポレイテッド | 放射線治療と組み合わせたvegfアンタゴニストの使用 |
CA2568534A1 (en) * | 2004-06-18 | 2006-01-26 | Regeneron Pharmaceuticals, Inc. | Vegf inhibitors for the treatment of malignant pleural effusion |
FR2878749B1 (fr) * | 2004-12-03 | 2007-12-21 | Aventis Pharma Sa | Combinaisons antitumorales contenant en agent inhibiteur de vegt et du 5fu ou un de ses derives |
-
2007
- 2007-07-05 FR FR0704868A patent/FR2918279B1/fr active Active
-
2008
- 2008-07-02 CN CN201610141168.3A patent/CN105833244A/zh active Pending
- 2008-07-02 KR KR1020157010064A patent/KR20150048910A/ko not_active Application Discontinuation
- 2008-07-02 AT AT08827826T patent/ATE500829T1/de active
- 2008-07-02 BR BRPI0812835A patent/BRPI0812835B8/pt active IP Right Grant
- 2008-07-02 PL PL08827826T patent/PL2173349T3/pl unknown
- 2008-07-02 DE DE602008005457T patent/DE602008005457D1/de active Active
- 2008-07-02 MX MX2009013950A patent/MX2009013950A/es active IP Right Grant
- 2008-07-02 CA CA2693152A patent/CA2693152C/fr not_active Expired - Fee Related
- 2008-07-02 RU RU2010103781/15A patent/RU2471483C2/ru active Protection Beyond IP Right Term
- 2008-07-02 AU AU2008290442A patent/AU2008290442B2/en active Active
- 2008-07-02 CN CN200880023537A patent/CN101686975A/zh active Pending
- 2008-07-02 ES ES08827826T patent/ES2362637T3/es active Active
- 2008-07-02 PT PT08827826T patent/PT2173349E/pt unknown
- 2008-07-02 CN CN201310556556.4A patent/CN103623392A/zh active Pending
- 2008-07-02 JP JP2010514042A patent/JP2010532335A/ja active Pending
- 2008-07-02 WO PCT/FR2008/000943 patent/WO2009024667A2/fr active Application Filing
- 2008-07-02 DK DK08827826.2T patent/DK2173349T3/da active
- 2008-07-02 RS RS20110215A patent/RS51777B/en unknown
- 2008-07-02 KR KR1020107000011A patent/KR20100031123A/ko not_active Application Discontinuation
- 2008-07-02 SI SI200830256T patent/SI2173349T1/sl unknown
- 2008-07-02 KR KR1020167017056A patent/KR20160079918A/ko not_active Application Discontinuation
- 2008-07-02 EP EP08827826A patent/EP2173349B1/de active Active
- 2008-07-02 KR KR1020187026491A patent/KR20180105261A/ko not_active Application Discontinuation
- 2008-07-04 AR ARP080102894A patent/AR067420A1/es not_active Application Discontinuation
-
2010
- 2010-01-04 IL IL203132A patent/IL203132A/en active IP Right Grant
- 2010-01-04 US US12/651,767 patent/US20100160233A1/en not_active Abandoned
-
2011
- 2011-06-08 CY CY20111100551T patent/CY1111675T1/el unknown
- 2011-06-09 HR HR20110432T patent/HRP20110432T1/hr unknown
-
2014
- 2014-01-13 US US14/153,795 patent/US20140127202A1/en not_active Abandoned
- 2014-08-29 JP JP2014174963A patent/JP2014240422A/ja active Pending
-
2015
- 2015-08-31 IL IL240965A patent/IL240965A0/en unknown
-
2016
- 2016-11-16 JP JP2016222826A patent/JP2017052789A/ja active Pending
-
2018
- 2018-08-15 JP JP2018152805A patent/JP2019006785A/ja active Pending
-
2019
- 2019-02-11 US US16/272,315 patent/US20190275147A1/en not_active Abandoned
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ATE500829T1 (de) | Antitumor-kombinationen mit einem vegf-hemmenden mittel und irinotecan | |
ATE488227T1 (de) | Feste zubereitung mit alogliptin und pioglitazon | |
ZA201204480B (en) | Conjugate with target-finding ligand and use thereof | |
EP2187957A4 (de) | Selektive cytopheresevorrichtungen und entsprechende verfahren | |
BRPI0812367A2 (pt) | Dispositivos interoclusais e respectivos métodos de fabrico | |
PL2036882T3 (pl) | Związki o jonach obojnaczych i ich zastosowanie | |
IL205571A0 (en) | 4-pyrazolyl-n-arylpyrimidin-2-amines and 4-pyrazolyl-n-heteroarylpyrimidin | |
GB2447532B (en) | Devices and methods for use in construction | |
EP2217371A4 (de) | Katalysatoren und zugehörige verfahren | |
BRPI0809978A2 (pt) | Dispositivos e métodos de dispensação de gotículas | |
EP2130575A4 (de) | Wabensegment | |
EP2150571A4 (de) | Polyalkylsilsesquioxanpartikel und verfahren zu ihrer herstellung | |
DE112008002974T8 (de) | Masseanschlussfahne und Erdungsvorrichtung hiermit | |
ZA200909059B (en) | Hydrocarbon mixtures and use thereof | |
PL2222981T3 (pl) | Środki napędowe i napęd łańcuchowy | |
IL194751A0 (en) | Drugs and uses | |
ATE526567T1 (de) | Zusammensteller und zusammenstellungsverfahren | |
EP2081950A4 (de) | Mit irinotecan-behandlung assoziierte expressionsprofile | |
IL208771A0 (en) | Iminopyridine derivatives and use thereof | |
EP2247190A4 (de) | Gummistrukturmischsysteme und verfahren | |
IL209361A0 (en) | Combination therapy with pm00104 and another antitumor agent | |
DE602007012059D1 (de) | N und elektrofahrzeug | |
ZA201005482B (en) | New macrolides and their use | |
IL206104A0 (en) | Aminothiazoles and their uses | |
DE112008004261A5 (de) | Schichtabscheidevorrichtung und Schichtabscheideverfahren |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
UEP | Publication of translation of european patent specification |
Ref document number: 2173349 Country of ref document: EP |